Cleared Traditional

K181310 - HeartCheck Cardi Beat ECG Monitor with ...

K181310 is the FDA 510(k) clearance for HeartCheck Cardi Beat ECG Monitor with ... by Cardiocomm Solutions, Inc.. It is a Class 2 Cardiovascular device (product code DXH) cleared through the Traditional 510(k) pathway after a 281-day FDA review.

K181310 · Cardiocomm Solutions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2019
Decision
281d
Days
Class 2
Risk

K181310 is an FDA 510(k) clearance for the HeartCheck Cardi Beat ECG Monitor with GEMS Mobile. Classified as Transmitters And Receivers, Electrocardiograph, Telephone (product code DXH), Class II - Special Controls.

Submitted by Cardiocomm Solutions, Inc. (North York, CA). The FDA issued a Cleared decision on February 22, 2019 after a review of 281 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2920 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardiocomm Solutions, Inc. devices

Submission Details

510(k) Number K181310 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 2018
Decision Date February 22, 2019
Days to Decision 281 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
156d slower than avg
Panel avg: 125d · This submission: 281d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXH Transmitters And Receivers, Electrocardiograph, Telephone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXH Transmitters And Receivers, Electrocardiograph, Telephone

All 92
Devices cleared under the same product code (DXH) and FDA review panel - the closest regulatory comparables to K181310.
Study Watch with Irregular Pulse Monitor
K192415 · Verily Life Sciences, LLC · Jan 2020
Triangle System
K183319 · AliveCor, Inc. · May 2019
KardiaMobile, KardiaStation
K182396 · AliveCor, Inc. · Apr 2019
RX-1 Rhythm Express Remote Cardiac Monitoring System
K183704 · Vivaquant, Inc. · Feb 2019
Coala Heart Monitor
K182040 · Coala Life AB · Feb 2019
Study Watch
K182456 · Verily Life Sciences, LLC · Jan 2019